Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;21(2):122-136.
doi: 10.1631/jzus.B1900422. Epub 2020 Feb 5.

Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis

Affiliations
Review

Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis

Wei Zhu et al. J Zhejiang Univ Sci B. 2020.

Abstract

Polypyrimidine tract-binding protein 1 (PTBP1) plays an essential role in splicing and is expressed in almost all cell types in humans, unlike the other proteins of the PTBP family. PTBP1 mediates several cellular processes in certain types of cells, including the growth and differentiation of neuronal cells and activation of immune cells. Its function is regulated by various molecules, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA-binding proteins. PTBP1 plays roles in various diseases, particularly in some cancers, including colorectal cancer, renal cell cancer, breast cancer, and glioma. In cancers, it acts mainly as a regulator of glycolysis, apoptosis, proliferation, tumorigenesis, invasion, and migration. The role of PTBP1 in cancer has become a popular research topic in recent years, and this research has contributed greatly to the formulation of a useful therapeutic strategy for cancer. In this review, we summarize recent findings related to PTBP1 and discuss how it regulates the development of cancer cells.

Keywords: Polypyrimidine tract-binding protein 1 (PTBP1); Alternative splicing; Glycolysis; M2 isoform of pyruvate kinase (PKM2); Cancer.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethics guidelines: Wei ZHU, Bo-lun ZHOU, Li-juan RONG, Li YE, Hong-juan XU, Yao ZHOU, Xue-jun YAN, Wei-dong LIU, Bin ZHU, Lei WANG, Xing-jun JIANG, and Cai-ping REN declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by any of the authors.

Figures

Fig. 1
Fig. 1
Location, structure, and formation of PTBP1 The PTBP1 gene is located on chromosome 19p13.3 in humans and has one N-terminal nuclear shuttling domain and four repeats of quasi-RNA recognition motif (RRM) domains. NLS: nuclear localization signal
Fig. 2
Fig. 2
Functions and regulation of PTBP1 in normal cells PTBP1 functions mainly in neuronal cells, in which it interacts with Pnky, miR-124, PSD-95, and Pbx1. PTBP1 regulates neurogenesis, NMD, transcription of neuronal genes, and tissue repair of neurogenic cells. It also regulates CD5 via alternative polyadenylation and CD40L and IL-2 via the PLCγ1/ERK1/2 and NF-κB pathways. PTBP1 regulates apoptosis via BIM and MCL1. miR-124: microRNA-124; PSD-95: postsynaptic density protein 95; NMD: nonsense-mediated mRNA decay; BIM: BCL-2-like 11; MCL1: myeloid cell leukemia 1; REST: repressor element 1 silencing transcription factor; PLCγ1: phospholipase Cγ1; ERK: extracellular signal-regulated kinase; NF-κB: nuclear factor-κB
Fig. 3
Fig. 3
Functions and regulatory roles of PTBP1 in cancer cells PTBP1 plays an important role in glycolysis, proliferation, invasion, apoptosis, and tumorigenesis. It is regulated by the miR-145/c-Myc and AP/β-catenin/c-Myc pathways. PTBP1 increases the transformation of PKM1 to PKM2, which is a crucial process for glycolysis. PKM2 increases the phosphorylation of Beclin-1 and mediates autophagic activation. PTBP1 inhibits the inclusion of an exonic splicing suppressor in exon 4 of the SRSF3 gene. This inhibition leads to the overexpression of SRSF3 and increases the transformation of PKM1 to PKM2. PTBP1 regulates tumorigenesis via CDC42-v1/v2 and regulates apoptosis via MCL1. CDC42: cell division control protein 42 homolog; MCL1: myeloid cell leukemia 1; SRSF3: serine and arginine-rich splicing factor 3; ERK: extracellular signal-regulated kinase; MEK: mitogen-activated protein kinase kinase; GSK-3: glycogen synthase kinase-3; PI3K: phosphoinositide 3-kinase; P: phosphorylation; AP: apigenin

Similar articles

Cited by

References

    1. Aldave G, Gonzalez-Huarriz M, Rubio A, et al. The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma. Neuro-Oncology. 2018;20(7):930–941. doi: 10.1093/neuonc/noy007. - DOI - PMC - PubMed
    1. Attig J, Agostini F, Gooding C, et al. Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing. Cell. 2018;174(5):1067–1081e17. doi: 10.1016/j.cell.2018.07.001. - DOI - PMC - PubMed
    1. Barbagallo D, Caponnetto A, Cirnigliaro M, et al. CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB. Int J Mol Sci. 2018;19(2):480. doi: 10.3390/ijms19020480. - DOI - PMC - PubMed
    1. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem. 2003;72:291–336. doi: 10.1146/annurev.biochem.72.121801.161720. - DOI - PubMed
    1. Brown CE, Mackall CL. CAR T cell therapy: inroads to response and resistance. Nat Rev Immunol. 2019;19(2):73–74. doi: 10.1038/s41577-018-0119-y. - DOI - PubMed

MeSH terms

Substances